GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Monday reported a fourth-quarter loss of $88 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $1.76. Losses, adjusted for non-recurring costs, were 31 cents per share.
The biopharmaceutical company posted revenue of $330.7 million in the period.
For the year, the company reported a loss of $223.8 million, or $4.47 per share, swinging to a loss in the period. Revenue was reported as $1.12 billion.
Emergent Biosolutions expects full-year revenue of $1.15 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
